170 related articles for article (PubMed ID: 25309902)
1. Dynamic of the cellular immune response at the dermal site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis infection in Sapajus apella primate.
Laurenti MD; Passero LF; Tomokane TY; Francesquini Fde C; Rocha MC; Gomes CM; Corbett CE; Silveira FT
Biomed Res Int; 2014; 2014():134236. PubMed ID: 25309902
[TBL] [Abstract][Full Text] [Related]
2. Experimental cutaneous leishmaniasis. IV. The humoral response of Cebus apella (Primates: Cebidae) to infections of Leishmania (Leishmania) amazonensis, L. (Viannia) lainsoni and L. (V.) braziliensis using the direct agglutination test.
Garcez LM; Silveira FT; el Harith A; Lainson R; Shaw JJ
Acta Trop; 1997 Oct; 68(1):65-76. PubMed ID: 9352003
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
[TBL] [Abstract][Full Text] [Related]
6. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.
de Moura TR; Novais FO; Oliveira F; Clarêncio J; Noronha A; Barral A; Brodskyn C; de Oliveira CI
Infect Immun; 2005 Sep; 73(9):5827-34. PubMed ID: 16113301
[TBL] [Abstract][Full Text] [Related]
7. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
8. [Experimental cutaneous leishmaniasis. III. Histopathological aspects of the developmental behavior of the cutaneous lesion induced in Cebus apella (Primates: Cebidae) by Leishmania (Viannia) lainsoni, L. (V.) braziliensis and L. (Leishmania) amazonensis].
Silveira FT; Moraes MA; Lainson R; Shaw JJ
Rev Inst Med Trop Sao Paulo; 1990; 32(6):387-94. PubMed ID: 2135483
[TBL] [Abstract][Full Text] [Related]
9. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
[TBL] [Abstract][Full Text] [Related]
10. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
[TBL] [Abstract][Full Text] [Related]
11. Interactions between Neutrophils and Leishmania braziliensis Amastigotes Facilitate Cell Activation and Parasite Clearance.
Carlsen ED; Jie Z; Liang Y; Henard CA; Hay C; Sun J; de Matos Guedes H; Soong L
J Innate Immun; 2015; 7(4):354-63. PubMed ID: 25766649
[TBL] [Abstract][Full Text] [Related]
12. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
13. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
14. The Paradox of a Phagosomal Lifestyle: How Innate Host Cell-
Carneiro MB; Peters NC
Front Immunol; 2021; 12():728848. PubMed ID: 34557194
[TBL] [Abstract][Full Text] [Related]
15. A Cytokine Network Balance Influences the Fate of
Paiva MB; Ribeiro-Romão RP; Resende-Vieira L; Braga-Gomes T; Oliveira MP; Saavedra AF; Silva-Couto L; Albuquerque HG; Moreira OC; Pinto EF; Da-Cruz AM; Gomes-Silva A
Front Immunol; 2021; 12():656919. PubMed ID: 34276650
[TBL] [Abstract][Full Text] [Related]
16. Experimental infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the marmoset, Callithrix penicillata (Primates:Callithricidae).
Cuba CA; Ferreira V; Bampi M; Magalhães A; Marsden PD; Vexenat A; De Mello MT
Mem Inst Oswaldo Cruz; 1990; 85(4):459-67. PubMed ID: 2152198
[TBL] [Abstract][Full Text] [Related]
17. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.
Giudice A; Camada I; Leopoldo PT; Pereira JM; Riley LW; Wilson ME; Ho JL; de Jesus AR; Carvalho EM; Almeida RP
BMC Infect Dis; 2007 Feb; 7():7. PubMed ID: 17316450
[TBL] [Abstract][Full Text] [Related]
18. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva.
de Moura TR; Oliveira F; Novais FO; Miranda JC; Clarêncio J; Follador I; Carvalho EM; Valenzuela JG; Barral-Netto M; Barral A; Brodskyn C; de Oliveira CI
PLoS Negl Trop Dis; 2007 Nov; 1(2):e84. PubMed ID: 18060088
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity.
Silva VM; de-Araújo CF; Navarro IC; Oliveira PR; Pontes-de-Carvalho L
BMC Res Notes; 2015 May; 8():197. PubMed ID: 25971623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
